Cover Image
市場調查報告書

Med Discovery SA - 產品平台分析

Med Discovery SA - Product Pipeline Review - 2014

出版商 Global Markets Direct 商品編碼 199734
出版日期 內容資訊 英文 23 Pages
訂單完成後即時交付
價格
Back to Top
Med Discovery SA - 產品平台分析 Med Discovery SA - Product Pipeline Review - 2014
出版日期: 2014年08月14日 內容資訊: 英文 23 Pages
簡介

Med Discovery SA 是致力於開發前列腺、膀胱、卵巢等各癌症治療性蛋白質的生物製藥企業。

本報告提供Med Discovery SA的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

Med Discovery SA的基本資料

Med Discovery SA概要

  • 主要資訊
  • 企業資料

Med Discovery SA:R&D概要

  • 主要的治療範圍

Med Discovery SA:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品
  • 合作夥伴產品
    • 合作夥伴產品/聯合治療模式

Med Discovery SA:開發中產品概況

  • 臨床實驗階段的開發中產品
    • 第一階段的產品/聯合治療模式
  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式

Med Discovery SA:藥物簡介

  • MDPK-67b
  • MDP-01
  • MDRG-01

Med Discovery SA:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Med Discovery SA:暫停中的計劃

Med Discovery SA:總公司和子公司的所在地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC06152CDB

Summary

Global Markets Direct's, 'Med Discovery SA - Product Pipeline Review - 2014', provides an overview of the Med Discovery SA's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Med Discovery SA's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Med Discovery SA including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Med Discovery SA's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Med Discovery SA's pipeline products

Reasons to buy

  • Evaluate Med Discovery SA's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Med Discovery SA in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Med Discovery SA's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Med Discovery SA and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Med Discovery SA
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Med Discovery SA and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Med Discovery SA Snapshot
    • Med Discovery SA Overview
    • Key Information
    • Key Facts
  • Med Discovery SA - Research and Development Overview
    • Key Therapeutic Areas
  • Med Discovery SA - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Partnered Products
      • Partnered Products/Combination Treatment Modalities
  • Med Discovery SA - Pipeline Products Glance
    • Med Discovery SA - Clinical Stage Pipeline Products
      • Phase I Products/Combination Treatment Modalities
    • Med Discovery SA - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • Med Discovery SA - Drug Profiles
    • MDPK-67b
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • MDP-01
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • MDRG-01
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Med Discovery SA - Pipeline Analysis
    • Med Discovery SA - Pipeline Products by Target
    • Med Discovery SA - Pipeline Products by Route of Administration
    • Med Discovery SA - Pipeline Products by Molecule Type
    • Med Discovery SA - Pipeline Products by Mechanism of Action
  • Med Discovery SA - Dormant Projects
  • Med Discovery SA - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Med Discovery SA, Key Information
  • Med Discovery SA, Key Facts
  • Med Discovery SA - Pipeline by Indication, 2014
  • Med Discovery SA - Pipeline by Stage of Development, 2014
  • Med Discovery SA - Monotherapy Products in Pipeline, 2014
  • Med Discovery SA - Partnered Products in Pipeline, 2014
  • Med Discovery SA - Partnered Products/ Combination Treatment Modalities, 2014
  • Med Discovery SA - Phase I, 2014
  • Med Discovery SA - Preclinical, 2014
  • Med Discovery SA - Pipeline by Target, 2014
  • Med Discovery SA - Pipeline by Route of Administration, 2014
  • Med Discovery SA - Pipeline by Molecule Type, 2014
  • Med Discovery SA - Pipeline Products by Mechanism of Action, 2014
  • Med Discovery SA - Dormant Developmental Projects,2014
  • Med Discovery SA, Other Locations

List of Figures

  • Med Discovery SA - Pipeline by Top 10 Indication, 2014
  • Med Discovery SA - Pipeline by Stage of Development, 2014
  • Med Discovery SA - Monotherapy Products in Pipeline, 2014
  • Med Discovery SA - Pipeline by Top 10 Target, 2014
  • Med Discovery SA - Pipeline by Top 10 Route of Administration, 2014
  • Med Discovery SA - Pipeline by Top 10 Molecule Type, 2014
  • Med Discovery SA - Pipeline Products by Top 10 Mechanism of Action, 2014
Back to Top